GHK-Cu 50MG

Description

GHK-Cu is a copper-binding tripeptide composed of glycyl-L-histidyl-L-lysine complexed with divalent copper (Cu2+). The free tripeptide GHK was first isolated from human plasma by Loren Pickart in 1973, and the copper-bound complex has been a subject of biochemistry and matrix biology research for over five decades.

Research Context

Preclinical investigations have examined GHK-Cu in in vitro models of fibroblast biology, extracellular matrix deposition, and copper transport. Laboratory studies have explored the tripeptide in dermal and connective tissue cell-culture systems, including assays of collagen and decorin synthesis. Researchers have also studied GHK-Cu as a model compound for examining copper coordination chemistry in physiologically relevant peptide ligands, given the well-defined Cu2+ binding site formed by the glycyl-histidyl N-terminal motif. The compound continues to be cited across both peptide biochemistry and trace-metal biology research literature.

Reconstitution & Storage

• Recommended reconstitution: 5-10 mL bacteriostatic water per 50 mg vial, adjusted to protocol
• Storage: Lyophilized: 2-8°C (refrigerated), long-term -20°C. Reconstituted: 2-8°C, use within 28 days.
• Stability: Avoid freeze-thaw cycles. Protect from light.

Quality Specifications

Research Use Only Disclaimer

This product is sold strictly for laboratory and scientific research purposes. Not for human consumption, ingestion, or administration. Not intended to diagnose, treat, cure, or prevent any disease. Not approved by the FDA for any clinical use.